1. |
Shane AL, Sánchez PJ, Stoll BJ. Neonatal sepsis. Lancet, 2017, 390(10104): 1770‐1780.
|
2. |
leischmann-Struzek C, Goldfarb DM, Schlattmann P, et al. The global burden of paediatric and neonatal sepsis: a systematic review. Lancet Respir Med, 2018, 6(3): 223‐230.
|
3. |
Wagstaff JS, Durrant RJ, Newman MG, et al. Antibiotic treatment of suspected and confirmed neonatal sepsis within 28 days of birth: a retrospective analysis. Front Pharmacol, 2019, 10: 1191.
|
4. |
中华医学会儿科学分会新生儿学组, 中国医师协会新生儿科医师分会感染专业委员会. 新生儿败血症诊断及治疗专家共识(2019 年版). 中华儿科杂志, 2019, 57(4): 252-257.
|
5. |
中华医学会急诊学分会儿科学组, 中华医学会儿科学分会急诊血组、新生儿学组. 新生儿危重病例评分法(草案). 中华儿科杂志, 2001, 39(1): 42-43.
|
6. |
Dong Y, Speer CP. Late-onset neonatal sepsis: recent developments. Arch Dis Child Fetal Neonatal Ed, 2015, 100(3): F257‐F263.
|
7. |
刘慧强, 童笑梅. 极低/超低出生体重儿晚发败血症的临床分析. 中国当代儿科杂志, 2019, 21(10): 1038‐1043.
|
8. |
Patel P, Bhatia J. Total parenteral nutrition for the very low birth weight infant. Semin Fetal Neonatal Med, 2017, 22(1): 2‐7.
|
9. |
Lapillonne A, Fidler Mis N, Goulet O, et al. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: lipids. Clin Nutr, 2018, 37(6 Pt B): 2324‐2336.
|
10. |
Alcock G, Liley HG, Cooke L, et al. Prevention of neonatal late-onset sepsis: a randomised controlled trial. BMC Pediatr, 2017, 17(1): 98.
|
11. |
El Manouni El Hassani S, Berkhout DJC, Niemarkt HJ, et al. Risk factors for late-onset sepsis in preterm infants: a multicenter case-control study. Neonatology, 2019, 116(1): 42‐51.
|
12. |
Shaw AG, Sim K, Randell P, et al. Late-onset bloodstream infection and perturbed maturation of the gastrointestinal microbiota in premature infants. PLoS One, 2015, 10(7): e0132923.
|
13. |
楚燕芳, 余加林, 杜立中. 区分早发型和晚发型新生儿败血症的临床意义. 中华实用儿科临床杂志, 2015, 30(10): 743-746.
|
14. |
陈潇, 富建华. 新生儿败血症 229 例临床特点、病原学分布及转归分析. 中华实用儿科临床杂志, 2019, 34(10): 740-744.
|
15. |
Heida FH, Hulscher JB, Schurink M, et al. Bloodstream infections during the onset of necrotizing enterocolitis and their relation with the pro-inflammatory response, gut wall integrity and severity of disease in NEC. J Pediatr Surg, 2015, 50(11): 1837‐1841.
|
16. |
Dong Y, Speer CP. The role of Staphylococcus epidermidis in neonatal sepsis: guarding angel or pathogenic devil?. Int J Med Microbiol, 2014, 304(5/6): 513-520.
|
17. |
Heo JS, Shin SH, Jung YH, et al. Neonatal sepsis in a rapidly growing, tertiary neonatal intensive care unit: trends over 18 years. Pediatr Int, 2015, 57(5): 909‐916.
|
18. |
Nour I, Eldegla HE, Nasef N, et al. Risk factors and clinical outcomes for carbapenem-resistant Gram-negative late-onset sepsis in a neonatal intensive care unit. J Hosp Infect, 2017, 97(1): 52‐58.
|
19. |
崔雪薇, 薛辛东. 降钙素原及 C-反应蛋白联合检测在新生儿院内感染早期诊断中的意义. 中国小儿急救医学, 2016, 23(4): 222-226.
|
20. |
Ree IMC, Fustolo-Gunnink SF, Bekker V, et al. Thrombocytopenia in neonatal sepsis: incidence, severity and risk factors. PLoS One, 2017, 12(10): e0185581.
|